Some ten years ago the reason for inability to have a child No. 1 was STD. Nowadays it’s age. It is not infertility. The women seeking methods of assisted reproduction are simply too old to have a child naturally, without the available technologies. Can we buy time? The Prelude Fertility business plan is certainly based on the belief that we can.
According to the Forbes, which will publish the story of Prelude Fertility in its November 8 issue, Martin Varsavsky began thinking about Prelude about six years ago. A tech entrepreneur with interest in life sciences and his wife conceived their first child through IVF – and froze their eggs and sperm for future use. Keeping your eggs safe and frozen will start at $199 a month.
Prelude will target women in their late 20s to mid-30s and while critics say egg freezing for younger women as a risky, often unnecessary procedure that can give them a false sense of security, Varsavsky already purchased the thriving RBA practice and My Egg Bank, which freezes roughly 40% of all donor eggs in America. He already makes profit.
Even more interesting for in-fertility is the reason for the $200 million investment. Outdated marketing and an industry associated with failure: Roughly two-thirds of IVF cycles produce no baby, according to the Society for Assisted Reproductive Technology (SART). Prelude Fertility is hoping to change it. Sure, it will start with an interesting marketing and a definite YES to the question whether IVF is a highly profitable business.